Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Complete Remission in Renal Cell Carcinoma”

4 trials

Showing 4 of 4 results

Testing effectiveness (Phase 2)Looking for participantsNCT05817903
What this trial is testing

Axitinib Intensification Plus Nivolumab or Nivolumab Alone After Nivolumab Plus Ipilimumab in mRCC Patients

Who this might be right for
Metastatic Renal Cell Carcinoma
Consorzio Oncotech 118
Testing effectiveness (Phase 2)Study completedNCT01392183
What this trial is testing

Pazopanib Versus Temsirolimus in Poor-Risk Clear-Cell Renal Cell Carcinoma (RCC)

Who this might be right for
Kidney Cancer
M.D. Anderson Cancer Center 69
Post-approval studies (Phase 4)Study completedNCT01206764
What this trial is testing

A Trial of Everolimis in Patients With Advanced Renal Cell Carcinoma.

Who this might be right for
Renal Cell Carcinoma
Novartis Pharmaceuticals 143
Not applicableStudy completedNCT01934452
What this trial is testing

Prospective Observational Analysis Of CR With Sunitinib Treatment In mRCC Patients

Who this might be right for
Complete Remission in Renal Cell Carcinoma
Pfizer 77

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation